PMS-PHENOBARBITAL DIN 00178829
Health Canada record
| Active ingredient(s) | PHENOBARBITAL 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | N03AA02 PHENOBARBITAL |
| Original market date | 31-Dec-1957 |
| Current status date | 04-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PHENOBARBITAL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02382776 | EPIPHEN 30MG | VETOQUINOL N A INC | Tablet | PHENOBARBITAL 30 MG | Marketed |
| 02382784 | EPIPHEN 60MG | VETOQUINOL N A INC | Tablet | PHENOBARBITAL 60 MG | Marketed |
| 02557819 | JAMP PHENOBARBITAL | JAMP PHARMA CORPORATION | Tablet | PHENOBARBITAL 100 MG | Marketed |
| 02557800 | JAMP PHENOBARBITAL | JAMP PHARMA CORPORATION | Tablet | PHENOBARBITAL 60 MG | Marketed |
| 02557797 | JAMP PHENOBARBITAL | JAMP PHARMA CORPORATION | Tablet | PHENOBARBITAL 30 MG | Marketed |
| 02557789 | JAMP PHENOBARBITAL | JAMP PHARMA CORPORATION | Tablet | PHENOBARBITAL 15 MG | Marketed |
| 00178799 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 15 MG | Marketed |
| 00178810 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 60 MG | Marketed |
| 00178802 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 30 MG | Marketed |
| 00645575 | PMS-PHENOBARBITAL ELIXIR | PHARMASCIENCE INC | Solution | PHENOBARBITAL 5 MG | Marketed |
| 00588180 | BARBILIXIR ELX 4MG/ML | D.C. LABS LIMITED | Elixir | PHENOBARBITAL 4 MG | Cancelled Post Market |
| 02042894 | DONNATAL ELIXIR | WYETH-AYERST CANADA INC. | Elixir | PHENOBARBITAL 16.2 MG; HYOSCYAMINE SULFATE 0.1037 MG; ATROPINE SULFATE 0.0194 MG; SCOPOLAMINE HYDROBROMIDE 6.5 MCG | Cancelled Post Market |
| 01909282 | DONNATAL ELIXIR | AYERST LABORATORIES | Elixir | PHENOBARBITAL 16.2 MG; HYOSCYAMINE SULFATE 0.1037 MG; ATROPINE SULFATE 0.0194 MG; SCOPOLAMINE HYDROBROMIDE 6.5 MCG | Cancelled Post Market |
| 01909274 | DONNATAL EXTENTABS | AYERST LABORATORIES | Tablet (Extended-Release) | PHENOBARBITAL 48.6 MG; HYOSCYAMINE SULFATE 0.3111 MG; ATROPINE SULFATE 0.0582 MG; SCOPOLAMINE HYDROBROMIDE 0.0195 MG | Cancelled Post Market |
| 02042908 | DONNATAL EXTENTABS SRT | WYETH-AYERST CANADA INC. | Tablet (Extended-Release) | PHENOBARBITAL 48.6 MG; HYOSCYAMINE SULFATE 0.3111 MG; ATROPINE SULFATE 0.0582 MG; SCOPOLAMINE HYDROBROMIDE 0.0195 MG | Cancelled Post Market |
| 02042916 | DONNATAL TAB | WYETH-AYERST CANADA INC. | Tablet | PHENOBARBITAL 16.2 MG; HYOSCYAMINE SULFATE 0.1037 MG; ATROPINE SULFATE 0.0194 MG; SCOPOLAMINE HYDROBROMIDE 6.5 MCG | Cancelled Post Market |
| 00344036 | PHENOBARBITAL 100MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | PHENOBARBITAL 100 MG | Cancelled Post Market |
| 00271276 | PHENOBARBITAL TAB 15MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | PHENOBARBITAL 15 MG | Cancelled Post Market |
| 00023795 | PHENOBARBITAL TAB 15MG | ERFA CANADA 2012 INC | Tablet | PHENOBARBITAL 15 MG | Cancelled Post Market |
| 00023809 | PHENOBARBITAL TAB 30MG | ERFA CANADA 2012 INC | Tablet | PHENOBARBITAL 30 MG | Cancelled Post Market |
| 00293903 | PHENOBARBITAL TAB 30MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | PHENOBARBITAL 30 MG | Cancelled Post Market |
| 00320714 | PHENOBARBITAL TAB 60MG | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | PHENOBARBITAL 60 MG | Cancelled Post Market |
| 00023817 | PHENOBARBITAL TAB 60MG | ERFA CANADA 2012 INC | Tablet | PHENOBARBITAL 60 MG | Cancelled Post Market |
| 00093564 | PHENOBARBITAL TABLET 100MG | D.C. LABS LIMITED | Tablet | PHENOBARBITAL 100 MG | Cancelled Post Market |
| 00093505 | PHENOBARBITAL TABLET 15MG | D.C. LABS LIMITED | Tablet | PHENOBARBITAL 15 MG | Cancelled Post Market |
| 00093521 | PHENOBARBITAL TABLET 30MG | D.C. LABS LIMITED | Tablet | PHENOBARBITAL 30 MG | Cancelled Post Market |
| 00093556 | PHENOBARBITAL TABLET 60MG | D.C. LABS LIMITED | Tablet | PHENOBARBITAL 60 MG | Cancelled Post Market |
| 02509547 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 60 MG | Cancelled Pre Market |
| 02509555 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 100 MG | Cancelled Pre Market |
| 02509539 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 30 MG | Cancelled Pre Market |
| 02509520 | PMS-PHENOBARBITAL | PHARMASCIENCE INC | Tablet | PHENOBARBITAL 15 MG | Cancelled Pre Market |
| 02509563 | PMS-PHENOBARBITAL ELIXIR | PHARMASCIENCE INC | Solution | PHENOBARBITAL 5 MG | Cancelled Pre Market |
International API supply for PHENOBARBITAL
6 valid EDQM Certificates of Suitability from 6 holders. 7 active FDA Drug Master Files.
Request a quote for PMS-PHENOBARBITAL